List of Oncology Medication For

Multiple Myeloma

APHEXDA (motixafortide) Injection

Multiple Myeloma, Transplant, Uncategorized

Brand Name: APHEXDA. Generic Name: (motixafortide). APHEXDA (motixafortide) is used with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.

APHEXDA is a prescription drug that in combination with filgrastim (a granulocyte-colony stimulating factor [G-CSF]) mobilizes hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.

Brand Name:	APHEXDA
Generic Name:	motixafortide
Strength:	For Injection: 62 mg as a lyophilized powder in a single-dose vial for reconstitution.
Manufacturer:	BioLineRx
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “APHEXDA (motixafortide)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for APHEXDA (motixafortide) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

Belantamab Mafodotin-blmf for Injection

Multiple Myeloma

belantamab mafodotin-blmf
for injection, for intravenous use Initial U.S. Approval: 2020

Blenrep (belantamab mafodotin-blmf) is a medication used for the treatment of adult patients with relapsed or refractory multiple myeloma whose disease has progressed despite prior treatment with an immunomodulatory agent, proteasome inhibitor and anti-CD38 antibody.

Facts about belantamab mafodotin-blmf for injection

Disease Indications-Multiple Myeloma
Manufacturer-GlaxoSmithKline
Usage-Intravenous
Medicine Approved By-European Medical Agency (EMA), Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “belantamab mafodotin-blmf for injection” based on the information you provide.

Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India. With over two decades of industry experience, IPN offers extensive coverage across India, including prominent cities such as Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Bortezomib for Injection

Multiple Myeloma, Lymphoma

Bortezomib Injection
for subcutaneous use Initial U.S. Approval: 2003

bortezomib is a proteasome inhibitor indicated for:
• treatment of patients with multiple myeloma
• treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.

Facts about Bortezomib for Injection

Approval Date: 2003
Proprietary Name: On Request
Active Ingredient(s): Bortezomib for Injection
Dosage Forms And Strengths:
Manufacturer:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Bortezomib for Injection” based on the information you provide.

Carfilzomib for Injection

Multiple Myeloma

carfilzomib for Injection
for intravenous use Initial U.S. Approval: 2012

Carfilzomib injection is used alone and in combination with other medications to treat people with multiple myeloma (a type of cancer of the bone marrow) who have already been treated with other medications. Carfilzomib is in a class of medications called proteasome inhibitors.

Facts about carfilzomib for Injection

Approval Date: 2012
Proprietary Name: On Request
Active Ingredient(s): carfilzomib for Injection
Dosage Forms And Strengths: Single-use vial: 60 mg sterile lyophilized powder
Current indications: multiple myeloma
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “carfilzomib for Injection” based on the information you provide.

Daratumumab injection

Multiple Myeloma

daratumumab injection
for intravenous use Initial U.S. Approval

Darzalex (daratumumab) is a human CD38-directed monoclonal antibody used to treat multiple myeloma.

Facts about daratumumab injection

DISEASE INDICATIONS-Multiple Myeloma
MANUFACTURER-Janssen-Cilag International N.V.
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA),Health Canada,Therapeutic Goods Administration (TGA),Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “daratumumab injection” based on the information you provide.

Elotuzumab for injection

Multiple Myeloma

elotuzumab for injection
for intravenous use Initial U.S. Approval: 2015

Empliciti (elotuzumab) is a medication, used in combination with lenalidomide and dexamethasone, for the treatment of multiple myeloma in patients who have received one to three prior therapies.

Facts about elotuzumab Intravenous infusion

DISEASE INDICATIONS-Multiple Myeloma
MANUFACTURER-Bristol-Myers Squibb
USAGE- 1 vial of powder for infusion of 300 mg
MEDICINE APPROVED BY-European Medical Agency (EMA),Food and Drug Administration (FDA),Therapeutic Goods administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “elotuzumab for injection” based on the information you provide.

Isatuximab-irfc Injection

Multiple Myeloma

isatuximab-irfc injection
for intravenous use Initial U.S. Approval: 2020

Sarclisa (isatuximab) is a medication used in combination with pomalidomide and dexamethasone or with carfilzomib and dexamethasone for the treatment of adults with relapsed refractory multiple myeloma (RRMM).

Facts about isatuximab-irfc injection

Disease Indications- Multiple Myeloma
Manufacturer- Sanofi
Usage- Intravenous
Medicine Approved By- European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada
Summary of FDA- approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “isatuximab-irfc injection” based on the information you provide.

ixazomib capsules

Multiple Myeloma

ixazomib capsules
for oral use Initial U.S. Approval: 2015

Ixazomib is a medication used for the treatment of multiple myeloma.

Facts about ixazomib capsules

DISEASE INDICATIONS-Multiple Myeloma
MANUFACTURER-Takeda Pharma A/S
USAGE-Oral
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada,
Pharmaceuticals and Medical Devices Agency (PMDA), Therapeutic Goods Administration (TGA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ixazomib capsules” based on the information you provide.

Lenalidomide Capsules

Multiple Myeloma, Lymphoma

lenalidomide capsules
for oral use Initial US Approval: 2005

Facts about lenalidomide capsules

Approval Date: 2005
Proprietary Name: On Request
Active Ingredient(s): Lenalidomide
Dosage Forms And Strengths: Capsules: 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg
Company: Bristol Myers Squibb
Diseases: Multiple myeloma, myelodysplastic syndromes, mantle cell lymphoma, follicular lymphoma and marginal zone lymphoma. It is used also in patients with myelodysplastic syndrome associated with a deletion 5q cytogenetic abnormality.
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “lenalidomide capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Mavenclad (cladribine)

Neuro, Multiple Myeloma, Multiple Sclerosis

Mavenclad (cladribine)

Mavenclad (cladribine) is a brand-name oral tablet that’s prescribed for relapsing-remitting multiple sclerosis (MS) and active secondary progressive MS. This article covers topics such as side effects, dosage, and how Mavenclad works. Mavenclad belongs to a drug class called purine antimetabolites.

Brand Name:	Mavenclad
Generic Name:	cladribine
Strength:
Manufacturer:
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “Mavenclad (cladribine)” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for Mavenclad (cladribine) price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

« Older Entries

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Note

We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient.

Disclaimer

“Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is intended to provide general information about consultancy services offered by IPN and to help users access this information in a user friendly format. Certain information available on the website has been sourced from publicly available sources. While Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in believes such information to be reasonably accurate, Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in has not independently verified any of this information. All information on the IPN website is of general nature and is not a substitute for medical prescription. None of the medicines or products mentioned on the IPN website are manufactured or sold by IPN Pharma Network.

Privacy Policy

Please read the following statement to learn about our information gathering and dissemination practices in relation to our consultancy services (“Services”). Note: Our privacy policy is subject to change at any time without notice. To make sure you are aware of any changes, please review this policy periodically. By visiting the Indian Pharma Network

Health Information

“All information available on the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in is of general nature and is not a substitute for professional medical advice by a licensed practitioner. Indian Pharma Network (IPN) does not purport to provide any medical or health-related advice, even of general nature and therefore you should not use or consult the Indian Pharma Network (IPN) website www.indianpharmanetwork.co.in for any questions in relation to your health or medical condition.

Shipped Anti-Cancer Medicines.

Indian Pharma Network is registered medical pharmacy for Oncology Products in India. Helps you to access FDA approved Anti-Cancer-Medicines, no matter where you live. Sourcing each medicine for named patient use and overseeing every aspect of the shipping, customs and delivery. We have helped more than 6,000 patients. Send your enquiry to find the What is the cost of Anti Cancer Medicines in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India.

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support
info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

Multiple Myeloma

Brand Name: APHEXDA. Generic Name: (motixafortide). APHEXDA (motixafortide) is used with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.

belantamab mafodotin-blmf for injection, for intravenous use Initial U.S. Approval: 2020

Access the best support services globally

Bortezomib Injection for subcutaneous use Initial U.S. Approval: 2003

Facts about Bortezomib for Injection

Access the best support services globally

carfilzomib for Injection for intravenous use Initial U.S. Approval: 2012

Facts about carfilzomib for Injection

Access the best support services globally

daratumumab injection for intravenous use Initial U.S. Approval

Facts about daratumumab injection

Access the best support services globally

elotuzumab for injection for intravenous use Initial U.S. Approval: 2015

Facts about elotuzumab Intravenous infusion

Access the best support services globally

isatuximab-irfc injection for intravenous use Initial U.S. Approval: 2020

Access the best support services globally

ixazomib capsules for oral use Initial U.S. Approval: 2015

Facts about ixazomib capsules

Access the best support services globally

lenalidomide capsules for oral use Initial US Approval: 2005

Facts about lenalidomide capsules

Access the best support services globally

Mavenclad (cladribine)

Contact Info

Query Form For Medications

Note

Disclaimer

Privacy Policy

Health Information

Shipped Anti-Cancer Medicines.

Indian Pharma Network (IPN), New Delhi. India

belantamab mafodotin-blmf
for injection, for intravenous use Initial U.S. Approval: 2020

Bortezomib Injection
for subcutaneous use Initial U.S. Approval: 2003

carfilzomib for Injection
for intravenous use Initial U.S. Approval: 2012

daratumumab injection
for intravenous use Initial U.S. Approval

elotuzumab for injection
for intravenous use Initial U.S. Approval: 2015

isatuximab-irfc injection
for intravenous use Initial U.S. Approval: 2020

ixazomib capsules
for oral use Initial U.S. Approval: 2015

lenalidomide capsules
for oral use Initial US Approval: 2005